Allergic Angiitis

Search Trials
Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)
Status:
Not yet recruiting
Last Changed:
May 11, 2022
First Changed:
Mar 3, 2022
Disease(s):
Eosinophilic Granulomatosis With Polyangiitis
Intervention(s):
DepemokimabMepolizumabPlacebo matching mepolizumabPlacebo matching depemokimab
Study of Mepolizumab-based Regimen Compared to Conventional Therapeutic Strategy in Patients With Eosinophilic Granulomatosis With Polyangiitis (E-merge)
Status:
Not yet recruiting
Last Changed:
Sep 1, 2021
First Changed:
Sep 1, 2021
Disease(s):
Eosinophilic Granulomatosis With Polyangiitis
Intervention(s):
Mepolizumabcyclophosphamide/azathioprinePlacebo
Urinary T Cell Biomarker for Prediction in ANCA Glomerulonephritis
Status:
Active, not recruiting
Last Changed:
Mar 9, 2022
First Changed:
Mar 25, 2020
Disease(s):
Glomerulonephritis Acute
Intervention(s):
Flow cytometry analysis of urine samples
Urinary T Lymphocytes Predict Renal Flares in Patients With Inactive ANCA-associated Glomerulonephritis
Status:
Completed
Last Changed:
Mar 9, 2022
First Changed:
Jun 11, 2020
Disease(s):
Glomerulonephritis Acute
Intervention(s):
Analysis of urine samples with flow cytometry
PRagmatic Analysis of Vitamin D in ANCA-Associated Vasculitis
Status:
Active, not recruiting
Last Changed:
Feb 16, 2022
First Changed:
Feb 21, 2020
Disease(s):
ANCA-associated Vasculitis
Intervention(s):
vitamin D

Connect. Empower. Inspire.